Surfactant and perfluorocarbon aerosolization during different mechanical ventilation strategies by means of inhalation catheters: An in vitro study

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 1, 2012, Pages 23-31

  Murgia, Xabier ^a   Gastiasoro, Elena ^a   Mielgo, Victoria ^a   Ruiz Del Yerro, Estibaliz ^a   Alvarez Diaz, Francisco José ^a   Lafuente, Hector ^a   Valls I Soler, Adolf ^a   Gomez Solaetxe, Miguel Angel ^b   Rey Santano, Carmen ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Aerosol; Mechanical ventilation; Perfluorocarbon; Surfactant; Vapor pressure

Indexed keywords

FLUOROCARBON; PERFLUORODECHALIN; PERFLUOROOCTYL BROMIDE; PORACTANT; UNCLASSIFIED DRUG; WATER;

AEROSOL; AIRFLOW; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CATHETER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; ENDOTRACHEAL TUBE; IN VITRO STUDY; LUNG ARTERY PRESSURE; LUNG MODEL; PEAK INSPIRATORY FLOW; PRODUCT RECOVERY;

ADMINISTRATION, INHALATION; AEROSOLS; CATHETERS; FLUOROCARBONS; PRESSURE; PULMONARY SURFACTANTS; RESPIRATION; RESPIRATION, ARTIFICIAL;

EID: 84856745372     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0886     Document Type: Article

References (35)

1. Nishina K, Mikawa K, Takao Y, and Obara H: The efficacy of fluorocarbon, surfactant, and their combination for improving acute lung injury induced by intratracheal acidified infant formula. Anesth Analg. 2005;100:964-971. (Pubitemid 40404196)
2. Quintel M, Heine M, Hirschl RB, Tillmanns R, and Wessendorf V: Effects of partial liquid ventilation on lung injury in a model of acute respiratory failure: a histologic and morphometric analysis. Crit Care Med. 1998;26:833-843. (Pubitemid 28211393)
3. Chinese collaborative study group for neonatal diseases: Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre, randomized, controlled trial. Acta Paediatr. 2009;94:896-902.
4. Gastiasoro Cuesta E, Alvarez Díaz FJ, Arnaiz Renedo A, Fernández Ruanova B, Lopez-Heredia J, Roman Etxebarria L, Alfonso Sánchez LF, and Valls i Soler A: The cardiovascular effects of partial liquid ventilation in newborn lambs after meconium aspiration. Pediatr Crit Care Med. 2001;2: 334-339.
5. Leach CL, Holm BA, Morin III FC, Fuhrman BP, Papo MC, Steinhorn DM, and Herman LJ: Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant. J Pediatr. 1995;126:412-420.
6. Gastiasoro Cuesta E, Alvarez Díaz FJ, Rey Santano C, Arnaiz Renedo A, Loureiro Gonzalez B, and Valls i Soler A: Acute and sustained effects of Lucinactant versus Poractant-alfa on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Pediatrics. 2006;117: 295-303.
7. Sweet D, Bevilacqua G, Carnielli VP, Greisen G, Saugstad OD, Simeoni U, Speer CP, Valls-i-Soler A, and Halliday HL: European consensus guidelines on the manegement of neonatal respiratory distress syndrome. J Perinat Med. 2007;35: 175-186. (Pubitemid 46700981)
8. Guo ZL, Lu GP, Ren T, Zheng YH, Gong JY, Yu J, and Liang YJ: Partial liquid ventilation confers protection againts acute lung injury induced by endotoxin in juvenile piglets. Respir Physiol Neurobiol. 2009;167:221-226.
9. Overbeck MC, Pranikoff T, Yadao CM, and Hirschl RB: Efficacy of perfluorocarbon partial liquid ventilation on lung injury in a model of acute respiratory failure. Crit Care Med. 1996;24:1208-1214. (Pubitemid 26249375)
10. Hirschl RB, Parent A, Tooley R, McCracken M, Johnson K, Shaffer TH, Wolfson MR, and Bartlett RH: Liquid ventilation improves pulmonary function, gas exchange and lung injury in a model of respiratory failure. Ann Surg. 1995;221: 79-88.
11. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, deLemos RA, Fuhrman BP, for The LiquidVent Study Group: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med. 1996;335:761-767. (Pubitemid 26296535)
12. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tü-tüncüAS, and Slutsky AS: Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;173:882-889.
13. Kaiser JR, Gauss CH, and Williams DK: Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very low birth weight infants. J Pediatr. 2004;144:809-814. (Pubitemid 38858101)
14. Davies MW, Dunster KR, Wilson K, and Colditz PB: Perfluorocarbon dosing when starting partial liquid ventilation: haemodynamics and cerebral blood flow in preterm lambs. Neonatology. 2010;97:144-153.
15. Cowan F, Whitelaw A, Wertheim D, and Silverman M: Cerebral blood flow velocity changes after rapid administration of surfactant. Arch Dis Child. 1991;66:1105-1109.
16. Ruppert C, Kuchenbuch T, Boensch M, Schmidt S, Mathes U, Hillebrand V, Henneke I, Markart P, Reiss I, Schermuly RT, Seeger W, and Günther A: Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflammed lung. Crit Care Med. 2010;38:1584-1591.
17. Meinhardt JP, Schmittner M, Herrmann P, Mailer M, and Quintel M: Comparison of different inhalational perfluorocarbons in a rabbit model of acute lung injury. ASAIO J. 2005;51:85-91. (Pubitemid 40165258)
18. Bleyl JU, Ragaller M, TschöU, Regner M, Kanzow M, Hübler M, Rasche S, and Alberecht M: Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology. 1999;91:461-469. (Pubitemid 29365030)
19. Tashiro K, Yamada K, Li W-Z, Matsumoto Y, and Kobayashi T: Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats. Crit Care Med. 1996;24:488-494. (Pubitemid 26097843)
20. Dijk PH, Heikamp A, and Bambang Oetomo S: Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure. Intensive Care Med. 1997;23:1077-1081. (Pubitemid 27489925)
21. Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, and Absolom D: Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol. 1993;74:1256-1264. (Pubitemid 23118579)
22. Kelly KP, Stenson BJ, and Drummond GB: Randomized comparison of partial liquid ventilation, nebulised perfluorocarbon, porcine surfactant, artificial surfactant, and combined treatments on oxygenation, lung mechanics, and survival in rabbits after saline lung lavage. Intensive Care Med. 2000;26:1523-1530.
23. McCallion ON, Taylor KM, Thomas M, and Taylor AJ: Nebulization of fluids of different physicochemical properties with air-jer and ultrasonic nebulizers. Pharm Res. 1995;12:1682-1688. (Pubitemid 26004694)
24. Köhler E, Jilg G, Avenarius S, and Jorch G: Lung deposition after inhalation with various nebulisers in preterm infants. Arch Dis Child Fetal Neonat Ed. 2008;93:275-279.
25. Ellyett KM, Broadbent RS, Fawcett ER, and Campbell AJ: Surfactant aerosol treatment of the respiratory distress syndrome in the spontaneously breathing premature rabbit. Pediatr Res. 1996;39:953-957. (Pubitemid 26170972)
26. Rüdiger M, Gregor T, Burkhardt W, Proquitté H, Wauer RR, and Schmalisch G: Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of perfluorocarbon aerosol. J Crit Care. 2004;19:42-47. (Pubitemid 38525975)
27. Miller DD, Amin MM, Palmer LB, Shah AR, and Smaldone GC: Aerosol delivery and modern mechanical ventilation. Am J Respir Crit Care Med. 2003;168:1205-1209.
28. Ari A, Areabi H, Fink JB: Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care. 2010;55:837-844.
29. Finlay JB, Mitchell J, Baran G, and Pevler J: Delivery of medication as large particles at the carina of an in vitro lung model is effective using a nebulizing catheter. 2005;16:34-37.
30. Murgia X, Gastiasoro E, Mielgo V, Alvarez Díaz FJ, Lafuente H, Valls-i-Soler A, Gomez-Solaetxe MA, Larrabe JL, and Rey Santano C: Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study. JAMP. 2011;24:81-87.
31. von der Hardt K, Kandler MA, Brenn G, Scheuerer K, Schoof E, Dötsch J, and Rascher W: Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med. 2004;32:1200-1206. (Pubitemid 38620991)
32. Gregor T, Schmalisch G, Burkhardt W, Proquitté H, Wauer RR, and Rüdiger M: Aerosolization of perfluorocarbons during mechanical ventilation: an in vitro study. Intensive Care Med. 2003;29:1354-1360. (Pubitemid 37041165)
33. Lu KW, Perez-Gil J, and Taeusch HW: Kinematic viscosity of therapeutic pulmonary surfactants with added polimers. Biochim Biophys Acta. 2009;1788:632-637.
34. Quong MC, Thebaud B, and Finlay WH: A method for increasing jet nebulizer delivery efficiency for aerosol drug delivery in ventilated newborns: an in vitro study. Respir Care. 2006;51:1244-1250.
35. Davies MW, and Dunster KR: Effect of perfluorocarbon (perfluorooctyl bromide) vapor on tidal volume measurement during partial liquid ventilation. Crit Care Med. 2002; 30:1123-1125. (Pubitemid 34508038)